Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
Pelthos Therapeutics (NYSE American: PTHS) announced its participation in two upcoming investor conferences in September 2025. The company's CEO Scott Plesha and CFO Frank Knuettel II will represent Pelthos at the H.C. Wainwright 27th Annual Global Investment Conference in New York City and the Investor Summit Group Q3 Virtual Conference.
At the H.C. Wainwright conference, scheduled for September 8-10, 2025, management will deliver a presentation on September 10 at 10:30 A.M. ET and will be available for one-on-one meetings. The virtual Investor Summit Group conference will take place on September 16-17, 2025. A webcast of the H.C. Wainwright presentation will be available on Pelthos' website with a 90-day replay period.
Pelthos Therapeutics (NYSE American: PTHS) ha annunciato la partecipazione a due conferenze per investitori previste a settembre 2025. Il CEO Scott Plesha e il CFO Frank Knuettel II rappresenteranno Pelthos al H.C. Wainwright 27th Annual Global Investment Conference a New York e al Investor Summit Group Q3 Virtual Conference.
Alla conferenza H.C. Wainwright, in programma dal 8 al 10 settembre 2025, la direzione terrà una presentazione il 10 settembre alle 10:30 ET e sarà disponibile per incontri one-to-one. La conferenza virtuale Investor Summit Group si svolgerà il 16-17 settembre 2025. La presentazione H.C. Wainwright sarà trasmessa in webcast sul sito di Pelthos e resterà disponibile in replay per 90 giorni.
Pelthos Therapeutics (NYSE American: PTHS) anunció su participación en dos próximas conferencias para inversores en septiembre de 2025. El CEO Scott Plesha y el CFO Frank Knuettel II representarán a Pelthos en la H.C. Wainwright 27th Annual Global Investment Conference en Nueva York y en la Investor Summit Group Q3 Virtual Conference.
En la conferencia de H.C. Wainwright, programada del 8 al 10 de septiembre de 2025, la dirección ofrecerá una presentación el 10 de septiembre a las 10:30 a.m. ET y estará disponible para reuniones individuales. La conferencia virtual de Investor Summit Group tendrá lugar el 16 y 17 de septiembre de 2025. La presentación de H.C. Wainwright se podrá ver en webcast en el sitio web de Pelthos y quedará disponible en repetición durante 90 días.
Pelthos Therapeutics (NYSE American: PTHS)는 2025년 9월에 예정된 두 건의 투자자 컨퍼런스에 참가한다고 발표했습니다. CEO 스콧 플레샤(Scott Plesha)와 CFO 프랭크 크뉘텔 2세(Frank Knuettel II)가 뉴욕에서 열리는 H.C. Wainwright 제27회 연례 글로벌 투자 컨퍼런스와 Investor Summit Group Q3 Virtual Conference에 Pelthos를 대표해 참석합니다.
H.C. Wainwright 컨퍼런스는 2025년 9월 8일~10일에 개최되며, 경영진은 9월 10일 오전 10:30(동부시간)에 프레젠테이션을 진행하고 일대일 미팅에 응할 예정입니다. Investor Summit Group의 가상 컨퍼런스는 2025년 9월 16~17일에 개최됩니다. H.C. Wainwright 발표는 Pelthos 웹사이트에서 웹캐스트로 제공되며 90일간 재생할 수 있습니다.
Pelthos Therapeutics (NYSE American: PTHS) a annoncé sa participation à deux conférences investisseurs prévues en septembre 2025. Le PDG Scott Plesha et le directeur financier Frank Knuettel II représenteront Pelthos lors de la H.C. Wainwright 27th Annual Global Investment Conference à New York et de la Investor Summit Group Q3 Virtual Conference.
À la conférence H.C. Wainwright, prévue du 8 au 10 septembre 2025, la direction fera une présentation le 10 septembre à 10h30 (heure de l'Est) et sera disponible pour des réunions individuelles. La conférence virtuelle Investor Summit Group se tiendra les 16 et 17 septembre 2025. La présentation H.C. Wainwright sera diffusée en webcast sur le site de Pelthos et pourra être réécoutée pendant 90 jours.
Pelthos Therapeutics (NYSE American: PTHS) gab seine Teilnahme an zwei bevorstehenden Investorenkonferenzen im September 2025 bekannt. CEO Scott Plesha und CFO Frank Knuettel II werden Pelthos auf der H.C. Wainwright 27th Annual Global Investment Conference in New York City sowie auf der Investor Summit Group Q3 Virtual Conference vertreten.
Auf der H.C. Wainwright-Konferenz, die vom 8. bis 10. September 2025 stattfindet, wird das Management am 10. September um 10:30 Uhr ET eine Präsentation halten und für Einzelgespräche zur Verfügung stehen. Die virtuelle Investor Summit Group-Konferenz findet am 16. und 17. September 2025 statt. Ein Webcast der H.C. Wainwright-Präsentation wird auf der Pelthos-Website verfügbar sein und 90 Tage als Replay bereitstehen.
- None.
- None.
DURHAM, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today announced that Scott Plesha, CEO, and Frank Knuettel II, CFO, will participate in the upcoming September conferences: H.C. Wainwright 27th Annual Global Investment Conference and the Investor Summit Group Q3 Virtual Conference.
Investor Conference Details:
H.C. Wainwright 27th Annual Global Investment Conference
Location: Lotte New York Palace Hotel, New York City
Conference Dates: September 8-10, 2025
Presentation Date: September 10, 2025 at 10:30 A.M. ET
One on one meeting availability: September 10, 2025
Institutional investors interested in scheduling an in-person one-on-one meeting should contact their institutional sales rep or register for the conference via this LINK.
A webcast of the presentation will be available on the Events and Presentations pages of Pelthos’ website at https://pelthos.com. Archived replays will be available for 90 days following the event.
Investor Summit Group Q3 Virtual Conference
Location: Virtual
Conference Dates: September 16-17, 2025
To register for this event please visit this LINK.
About Pelthos Therapeutics
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens. The company’s lead product ZELSUVMI™ (berdazimer) topical gel,
Contacts
Pelthos Investor Inquiries:
Mike Moyer
Managing Director, LifeSci Advisors, LLC
mmoyer@lifesciadvisors.com
Media:
KWM Communications
Kellie Walsh / Rachel Kessler
pelthos@kwmcommunications.com
(914) 315-6072
FAQ
When is Pelthos Therapeutics (PTHS) presenting at the H.C. Wainwright Conference 2025?
Where can I watch Pelthos Therapeutics' (PTHS) H.C. Wainwright conference presentation?
Which executives from Pelthos Therapeutics (PTHS) will attend the September 2025 investor conferences?
What investor conferences is Pelthos Therapeutics (PTHS) attending in September 2025?
